Deepak Shukla
Has grant
Professor
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Deepak Shukla is a Professor at the University of Illinois at Chicago, USA. His research focuses on herpesvirus infections, particularly the mechanisms of immune regulation and the impact of these infections on various cellular processes. Recent publications include studies on HSV-1 and its effects on periodontal stem cells, neurobehavioral deficits, and the interplay of the virus with therapeutic targets.
Recent Grants
Grant: Close
A new molecular therapy against ocular herpes
Open Date: 2015-08-01
Close Date: 2018-07-31
Grant: Close
Novel Peptides Against Modified Heparan Sulfate
Open Date: 2014-09-01
Close Date: 2017-08-31
Grant: Close
Micro-nano Platforms for HSV Vaccine
Open Date: 2013-02-01
Close Date: 2016-01-31
Grant: Close
Role of Optineurin in Ocular Herpes Infection
Open Date: 2013-02-01
Close Date: 2016-01-31
Grant: Close
Significance of heparan sulfate in HSV-1 spread
Open Date: 2009-09-16
Close Date: 2014-07-31
Articles (19)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
The entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into human embryonic kidney (HEK293T) cells has been shown to be a cholesterol-rich, lipid raft-dependent process. In this study, we investigated if the presence of a cholesterol uptake receptor Niemann-pick type c1-like1 (NPC1L1) impacts SARS-CoV-2 cell entry. Initially, we utilized reporter-based pseudovirus cell entry assays and a spike (S) glycoprotein-mediated cell-to-cell fusion assay. Using Chinese hamster ovary (CHO-K1) cells, which lack endogenous receptors for SARS-CoV-2 entry, our data showed that the co-expression of NPC1L1 together with the ACE2 receptor synergistically increased SARS-CoV-2 pseudovirus entry even more than the cells expressing ACE-2 receptor alone. Similar results were also found with the HEK293T cells endogenously expressing the ACE2 receptor. Co-cultures of effector cells expressing S glycoprotein together with target cells co-expressing ACE-2 receptor with NPC1L1 significantly promoted quantitative cell-to-cell fusion, including syncytia formation. Finally, we substantiated that an elevated expression of NPC1L1 enhanced entry, whereas the depletion of NPC1L1 resulted in a diminished SARS-CoV-2 entry in HEK293T-ACE2 cells using authentic SARS-CoV-2 virus in contrast to their respective control cells. Collectively, these findings underscore the pivotal role of NPC1L1 in facilitating the cellular entry of SARS-CoV-2. Importance: Niemann-Pick type C1-like1 (NPC1L1) is an endosomal membrane protein that regulates intracellular cholesterol trafficking. This protein has been demonstrated to play a crucial role in the life cycle of several clinically important viruses. Although SARS-CoV-2 exploits cholesterol-rich lipid rafts as part of its viral entry process, the role of NPC1L1 in SARS-CoV-2 entry remains unclear. Our research represents the first-ever demonstration of NPC1L1’s involvement in facilitating SARS-CoV-2 entry. The observed role of NPC1L1 in human kidney cells is not only highly intriguing but also quite relevant. This relevance stems from the fact that NPC1L1 exhibits high expression levels in several organs, including the kidneys, and the fact that kidney damages are reported during severe cases of SARS-CoV-2. These findings may help us understand the new functions and mechanisms of NPC1L1 and could contribute to the identification of new antiviral targets.
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Collaborators (5)
Chandrashekhar Patil
Research Assistant Professor
University of Chicago
Shannon Payen
University of Nevada Reno
Michelle Swanson-Mungerson
-
Vaibhav Tiwari
Midwestern University
Abhijit Date
Associate Professor of Pharmaceutical Sciences
University of Arizona
Make your next move.
Prepare your application
Review drafts before you send them.